Use of Continuous Glucose Monitors in Publicly Insured Youth With Type 2 Diabetes: A 12-month Pilot and Feasibility Study
Authors' conclusion
Strategies for sustained CGM use in youth with T2D may differ from adults with T2D or youth with type 1 diabetes. Additional studies are needed to evaluate facilitators and barriers of sustained CGM use to optimize CGM use in youth with T2D.
Study context
- Population
- Publicly insured youth <20 years old with T2D; age 15.1 years (SD 2.48), HbA1c 10.2%, 46.7% female, 90% Hispanic
- Participants
- 30 participants
- Outcome
- CGM use: % wear time per two-week period (>75% wear-time as goal)
- Follow-up
- 12 months
Methodological detailssingle-group, 12-month, 37% previously used CGM and 53% lacked glucometer data at baseline
- Single-group
- 12-month
- 37% previously used CGM and 53% lacked glucometer data at baseline
Main finding
As reported in the abstract
CGM use
CGM use at three months
50%
CGM use at 12 months
23%
Decrease in CGM wear time by 12 months
6.4 days per two weeks
Further findings
HbA1c · 12 months
- Mean HbA1c at 12 months
- 9.8%
- Exploratory outcome
TIR (% time 70–180 mg/dl) · baseline to 12 months
- Median TIR decreased from 71% to 42%
- Exploratory outcome
Patient-reported outcomes (youth and parents)
- Parents and youth had moderate-to-positive attitudes about diabetes technology
- Youth endorsed fair global health; youth and parents endorsed fair general and diabetes-related health-related quality of life
- Exploratory outcome
Original publication
Use of Continuous Glucose Monitors in Publicly Insured Youth With Type 2 Diabetes: A 12-month Pilot and Feasibility Study. J Diabetes Sci Technol. Published 20 September 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →